By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


VaxInnate Corporation 

3 Cedar Brook Drive
Suite 1
Cranbury  New Jersey  08512  U.S.A.
Phone: 609 860 2260 Fax: 609 860 2290



Company News
VaxInnate Corporation Enhances R&D Program and Strengthens Senior Management Team to Drive Pipeline Development of Current and Potential Targets 5/13/2015 7:39:53 AM
VaxInnate Corporation To Present At Needham & Company 14th Annual Healthcare Conference 4/7/2015 7:57:04 AM
VaxInnate Corporation Receives Extension Of Contract From Biomedical Advanced Research and Development Authority (BARDA) For Development Of Seasonal And Pandemic Influenza Vaccines 2/17/2015 7:42:56 AM
VaxInnate Corporation Initiates Phase 1b/2 Clinical Trial Of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, In Elderly 12/8/2014 7:55:40 AM
VaxInnate Corporation Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, Meets Phase 1 Seasonal Influenza Endpoints 11/11/2014 7:14:11 AM
VaxInnate Corporation Updates Plans To Advance Lead Vaccine Candidate, VAX2012Q In Elderly 10/8/2014 7:25:51 AM
Well-Capitalized VaxInnate Corporation Gets Another $6 Million For Its Bacteria-Based Flu Vaccines 10/3/2014 8:00:33 AM
VaxInnate Corporation Begins Phase I Clinical Trial To Evaluate Quadrivalent Vaccine For Prevention Of Seasonal Flu 3/19/2014 8:59:31 AM
VaxInnate Corporation Receives $2.1 Million From New Jersey’s Technology Business Tax Certificate Transfer Program 1/28/2014 9:40:49 AM
VaxInnate Corporation Awarded U.S. Government Grant to Develop Dengue Vaccine 4/4/2013 11:44:13 AM